Research Holdings
Open
$0.87
Prev. Close
$0.87
High
$0.87
Low
$0.87
Market Snapshot
$41.22M
5.8
-1.53
$359.1M
320
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Recently from Cashu
Balancing AI Growth with Workforce Security and Ethical Responsibility in Innovation
Navigating the Dual Edges of AI Innovation The artificial intelligence (AI) sector stands at a transformative crossroads, generating remarkable wealth while posing significant challenges to the workfo…
AI Growth: Balancing Opportunities and Challenges for Workforce and Society
Navigating the Dual Edges of AI Growth: Opportunities and Challenges The artificial intelligence (AI) sector is undergoing a monumental transformation, marking its presence across industries and foste…
AI's Challenges and Opportunities: Balancing Innovation with Workforce Displacement
Artificial Intelligence's Dual Impact: Progress and Challenges in the Workforce The rapid expansion of the artificial intelligence (AI) sector presents a complex landscape defined by technological adv…
Expanding Innovations Launches Enabling Technologies Division to Revolutionize Spinal Surgery
Innovative Advances in Spinal Surgery: Expanding Innovations Launches Enabling Technologies Division Expanding Innovations, headquartered in Mountain View, California, takes a significant step forward…